Company Monitoring Page for Daiichi-Sankyo

latest headlines for company on cafepharma

Daiichi could be rewarded for persisting with Vanflyta
EP Vantage
Fri, 11/19/21 - 10:49 am
Tags:
Daiichi Sankyo, Vanflyta, AML
Daiichi jettisons ADC after flunking early solid tumor test
Fierce Biotech
Fri, 10/29/21 - 10:34 am
Tags:
Daiichi Sankyo, antibody-drug conjugate, GIST, DS-6157, solid tumors
Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio
BioSpace
Tue, 10/26/21 - 12:01 am
Tags:
Merck, Keytruda, Xeris Biopharma, XeriJect, Evaxion Biotech, EVX-01, Daiichi Sankyo, AstraZeneca, datopotamab deruxtecan
Enhertu nabs speedy FDA review for earlier use in breast cancer
Pharmaforum
Mon, 10/4/21 - 10:57 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer, FDA
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
Tags:
ESMO, Corbus Pharmaceuticals, Leap Therapeutics, Surface Oncology, AstraZeneca, Innate Pharma, Immunocore, Daiichi Sankyo, Verastem, Spectrum Pharrmaceuticals, Mirati Therapeutics
AstraZeneca, Daiichi Sankyo's ADC Enhertu blows away Roche's Kadcyla in second-line advanced breast cancer
Endpoints
Sat, 09/18/21 - 08:34 pm
Tags:
ESMO, AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer, Roche
ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals
Fierce Biotech
Fri, 09/17/21 - 11:06 am
Tags:
ESMO, Daiichi Sankyo, antibody-drug conjugate, DS-7300
AstraZeneca and Daiichi Sankyo continue to flesh out Enhertu plans, claiming win in earlier breast cancer line
Endpoints
Mon, 08/9/21 - 10:55 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer
Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty
Endpoints
Fri, 07/23/21 - 10:57 am
Tags:
Novartis, patents, Tafinlar, Plexxikon, Daiichi Sankyo
AstraZeneca, Daiichi Sankyo uncork new TNBC data for 2nd partnered ADC — and it's adding more heat under Gilead's Trodelvy
Endpoints
Sun, 05/9/21 - 10:58 pm
Tags:
AstraZeneca, Daiichi Sankyo, TNBC, antibody-drug conjugate
Daiichi exits combo vaccine pact with Sanofi after pertussis shot manufacturing glitches
Fierce Pharma
Wed, 03/31/21 - 10:53 pm
Tags:
Daiichi Sankyo, Sanofi, vaccines, VN-0105, pertussis, drug manufacturing
Daiichi takes mRNA COVID-19 vaccine into clinic as Japanese R&D belatedly fires up
Fierce Biotech
Mon, 03/22/21 - 10:37 am
Tags:
Daiichi Sankyo, MRNA, COVID-19, vaccines, Japan
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
Mon, 01/18/21 - 01:15 pm
Tags:
AstraZeneca, Daiichi Sankyo, stomach cancer, Enhertu, Roche, Herceptin
Sanofi inks COVID-19 mRNA vaccine deal with Translate BioDaiichi Sankyo’s Mirogabalin Displays Significant Reduction in Post-SCI Neuropathic Pain
BioSpace
Sat, 12/19/20 - 11:22 pm
Tags:
Daiichi Sankyo, gabapentinoid, central neuropathic pain after spinal cord injury, spinal cord injury
Daiichi Sankyo takes oncology shift into next phase with new global business unit
Fierce Pharma
Mon, 11/23/20 - 10:34 pm
Tags:
Daiichi Sankyo, oncology
Enhertu picks up another win for AstraZeneca and Daiichi Sankyo, joining the priority review lane for gastric cancer
Endpoints
Wed, 10/28/20 - 10:32 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, breakthrough status, FDA, metastatic gastric cancer, gastric cancer
Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
Pharmaceutical Business Review
Fri, 08/7/20 - 11:10 am
Tags:
Daiichi Sankyo, AstraZeneca, patritumab deruxtecan, Tagrisso, non-small cell lung cancer, clinical trials
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront
Motley Fool
Tue, 07/28/20 - 11:14 am
Tags:
AstraZeneca, DS-1062, Daiichi Sankyo
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
Pharmaforum
Mon, 07/27/20 - 11:00 am
Tags:
AstraZeneca, Daiichi Sankyo, DS-1062, antibodies, cancer
Daiichi Sankyo expands DS-1062 study to include patients with triple negative breast cancer
Pharmaceutical Business Review
Thu, 07/2/20 - 11:09 am
Tags:
Daiichi Sankyo, antibody-drug conjugate, triple negative breast cancer, DS-1062, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.